RARE Ultragenyx Pharmaceutical delivers 202 percent year over year revenue growth shares tick modestly higher post earnings NU Nu stock gains 035 percent even as its Q4 2025 EPS falls short of consensus analyst estimates DeepSeek R1 Launch Global AI Market and US Tech Sector Implications BPACR Blueport earnings report shows limited financial disclosure raising transparency questions among investors